| publication name | Arginine dimethylation products in pediatric patients with chronic kidney disease |
|---|---|
| Authors | Enas A.A. Abdallah Akram E. El-Sadekcorrespondenceemail , Eman G. Behery , Ahmed A. Azab , Naglaa M. Kamal , Mostafa A. Salama , Waleed E. Abdulghany |
| year | 2016 |
| keywords | |
| journal | Annals of Medicine and Surgery |
| volume | 9 |
| issue | Not Available |
| pages | 22-27 |
| publisher | Not Available |
| Local/International | International |
| Paper Link | Not Available |
| Full paper | download |
| Supplementary materials | Not Available |
Abstract
Background arginine and its metabolites have been linked to pediatric chronic kidney disease (CKD). We aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function. Patients and methods 132 pediatric patients with CKD and 120 healthy age and sex matched controls were compared regarding; serum Arg, ADMA and SDMA levels. Results In comparison to their values in control subjects, serum Arg levels were significantly lower; serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in CKD patients (p values: < 0.000; = 0.054;